Showing results (381-390 of 449) with videos related to
Sort By:
Pageof 45
Journal of Thrombosis and Haemostasis : JTH|September 14, 2010
Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcomeA A C M Heestermans, J W van Werkum, B Zwart, et al.Journal of Electrocardiology|April 5, 2016
The relationship between terminal QRS distortion on initial ECG and final infarct size at 4months in conventional ST- segment elevation myocardial infarct patientsM E C J Hassell, R Delewi, C P H Lexis, et al.European Journal of Preventive Cardiology|May 16, 2018
Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practiceJosé Tuñón, Magnus Bäck, Lina Badimón, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 30, 2010
Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trialJ D E Haeck, K T Koch, Y L Gu, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 29, 2021
Clinical consequences of consecutive self-expanding transcatheter heart valve iterationsH G Kroon, L van Gils, F Ziviello, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 25, 2022
Changes in demographics, treatment and outcomes in a consecutive cohort who underwent transcatheter aortic valve implantation between 2005 and 2020M J A G De Ronde-Tillmans, R M Nuis, J A Goudzwaard, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 8, 2009
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first resultsA van der Laan, A Hirsch, R Nijveldt, et al.The Journal of Experimental Medicine|January 27, 2010
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileEsther Lutgens, Dirk Lievens, Linda Beckers, et al.Nature Medicine|September 30, 1999
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureS Heymans, A Luttun, D Nuyens, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 19, 2009
Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular eventsDominique P V de Kleijn, Frans L Moll, Willem E Hellings, et al.Pageof 45